Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

480 public trials 127 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Recruiting

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

NCT06596694

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Cancer, +4 more
Locations
  • UCLA Hematology Oncology Santa Monica ( Site 1205) Santa Monica, California, United States
  • University of Colorado Cancer Center ( Site 1200) Aurora, Colorado, United States
  • Sibley Memorial Hospital ( Site 1208) Washington D.C., District of Columbia, United States
  • University of Florida ( Site 1202) Gainesville, Florida, United States
View all 62 locations
View Trial Details
Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

NCT07222800

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +13 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Ironwood Cancer & Research Centers Gilbert, Arizona, United States
  • Ironwood Cancer & Research Centers Glendale, Arizona, United States
  • Ironwood Cancer & Research Centers Goodyear, Arizona, United States
View all 285 locations
View Trial Details
Recruiting

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed

NCT06885034

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • GSK Investigational Site Los Alamitos, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Santa Monica, California, United States
  • GSK Investigational Site Whittier, California, United States
View all 85 locations
View Trial Details
Recruiting

ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Digestive Cancers

NCT05441163

Conditions
Cancer, Digestive System Diseases, Digestive System Neoplasms, +4 more
Locations
  • CHRU de Tours Tours, Institut Curie, France
  • Institut du cancer Avignon-Provence Avignon, France
  • Institut Bergonié Bordeaux, France
  • Centre de Lutte Contre le Cancer Jean Perrin Clermont-Ferrand, France
View all 18 locations
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details

Related conditions